Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-003886
Filing Date
2024-12-02
Accepted
2024-12-02 07:03:47
Documents
2
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 6-K zk2432417.htm 6-K 26687
2 image00002.jpg GRAPHIC 3952
  Complete submission text file 0001178913-24-003886.txt   33247
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 241517395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)